Literature DB >> 11795771

Insurance, genetic testing and familial cancer: recent policy changes in the United Kingdom.

P J Morrison.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11795771      PMCID： PMC2449245     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


× No keyword cloud information.
  17 in total

1.  Genetic testing, adverse selection, and the demand for life insurance.

Authors:  C D Zick; K R Smith; R N Mayer; J R Botkin
Journal:  Am J Med Genet       Date:  2000-07-03

2.  Laws restricting health insurers' use of genetic information: impact on genetic discrimination.

Authors:  M A Hall; S S Rich
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Presymptomatic testing for Huntington's disease in Wales 1987-90.

Authors:  A Tyler; M Morris; L Lazarou; L Meredith; J Myring; P Harper
Journal:  Br J Psychiatry       Date:  1992-10       Impact factor: 9.319

4.  Health, life and disability insurance and hereditary risk for breast or colorectal cancer.

Authors:  J Norum; L Tranebjaerg
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

5.  Insurance and genetic testing.

Authors:  P S Harper
Journal:  Lancet       Date:  1993-01-23       Impact factor: 79.321

6.  Factors influencing health insurers' decisions to cover new genetic technologies.

Authors:  M M Schoonmaker; B A Bernhardt; N A Holtzman
Journal:  Int J Technol Assess Health Care       Date:  2000       Impact factor: 2.188

7.  Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group.

Authors:  H F Vasen; N E Haites; D G Evans; C M Steel; P Møller; S Hodgson; D Eccles; P Morrison; D Stoppa Lyonet; J Chang-Claude; M Caligo
Journal:  Eur J Cancer       Date:  1998-11       Impact factor: 9.162

8.  Ethical and legal dilemmas arising during predictive testing for adult-onset disease: the experience of Huntington disease.

Authors:  M Huggins; M Bloch; S Kanani; O W Quarrell; J Theilman; A Hedrick; B Dickens; A Lynch; M Hayden
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

9.  Cancer genetics services in Europe.

Authors:  S Hodgson; B Milner; I Brown; G Bevilacqua; J Chang-Claude; D Eccles; G Evans; H Gregory; P Møller; P Morrison; M Steel; D Stoppa-Lyonnet; H Vasen; N Haites
Journal:  Dis Markers       Date:  1999-10       Impact factor: 3.434

10.  Genetic testing and insurance.

Authors:  P S Harper
Journal:  J R Coll Physicians Lond       Date:  1992-04
View more
  3 in total

1.  The RET mutation E768D confers a late-onset familial medullary thyroid carcinoma -- only phenotype with incomplete penetrance: implications for screening and management of carrier status.

Authors:  Tabib Dabir; Steven J Hunter; Colin F J Russell; Damien McCall; Patrick J Morrison
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 2.  Hereditary non-polyposis colon cancer.

Authors:  L A Devlin; J H Price; P J Morrison
Journal:  Ulster Med J       Date:  2005-05

3.  Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.

Authors:  M Watson; C Foster; R Eeles; D Eccles; S Ashley; R Davidson; J Mackay; P J Morrison; P Hopwood; D G R Evans
Journal:  Br J Cancer       Date:  2004-11-15       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.